» Articles » PMID: 39055409

Mycobacterium Tuberculosis and Mycobacterium Avium Coinfection in an Immunocompetent Patient

Overview
Journal Cureus
Date 2024 Jul 26
PMID 39055409
Authors
Affiliations
Soon will be listed here.
Abstract

Despite the increasing incidence of simultaneous mycobacterial and non-mycobacterial tuberculosis (TB) infection, little literature is available exploring the topic. Here, we present a case of a 22-year-old female diagnosed with pulmonary TB for four months with simultaneous multiple sputum cultures positive for non-tuberculous mycobacteria (NTM). Computed tomography of the chest without contrast reported linear areas of scarring involving both lung apices, more prominent on the left side. The patient completed intensive phase treatment for TB and is currently on isoniazid and rifampin with a referral to an infectious disease specialist for recommendations on treatment of regimen in view of azithromycin allergy (intense cough and rash). While the coexistence of NTM is commonly attributed to colonization, differentiating colonization from disease is crucial considering the long duration of treatment, potential drug toxicity, risk of drug resistance, and significant cost of treatment. Clinical, microbiological, and radiological evidence should be considered for diagnosis of TB and NTM coinfection and expert consultation should be sought in formulating the treatment plan.

References
1.
Tortoli E . Clinical manifestations of nontuberculous mycobacteria infections. Clin Microbiol Infect. 2009; 15(10):906-10. DOI: 10.1111/j.1469-0691.2009.03014.x. View

2.
Joao I, Bujdakova H, Jordao L . Opportunist Coinfections by Nontuberculous Mycobacteria and Fungi in Immunocompromised Patients. Antibiotics (Basel). 2020; 9(11). PMC: 7693372. DOI: 10.3390/antibiotics9110771. View

3.
Catanzaro A . Diagnosis, differentiating colonization, infection, and disease. Clin Chest Med. 2002; 23(3):599-601, vi. DOI: 10.1016/s0272-5231(02)00020-5. View

4.
Urabe N, Sakamoto S, Shimanuki Y, Kanokogi T, Motohashi T, Anzai N . Impact of chronic co-infection in pulmonary Mycobacterium avium complex disease after treatment initiation. BMC Pulm Med. 2022; 22(1):157. PMC: 9036801. DOI: 10.1186/s12890-022-01947-7. View

5.
Khan Z, Miller A, Bachan M, Donath J . Mycobacterium Avium Complex (MAC) Lung Disease in Two Inner City Community Hospitals: Recognition, Prevalence, Co-Infection with Mycobacterium Tuberculosis (MTB) and Pulmonary Function (PF) Improvements After Treatment. Open Respir Med J. 2011; 4:76-81. PMC: 3024567. DOI: 10.2174/1874306401004010076. View